James Koh
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cutaneous Melanoma Detection and Management
- Nephrology top 5%
- Parathyroid Disorders and Treatments
Papers in
-
- Epigenetics and DNA Methylation 6
- Metabolism, Diabetes, and Cancer 5
- Ubiquitin and proteasome pathways 3
- Oncology 14
- Cancer-related Molecular Pathways 9
- Co-authors
- Greg H. Enders (2 shared papers)Ed Harlow (1 shared paper)Brian David Dynlacht (1 shared paper)James C. Garbe (3 shared papers)Martha R. Stampfer (3 shared papers)Thomas J. Sferra (1 shared paper)FS Collins (1 shared paper)John A. Olson (5 shared papers)
- Journals
- Molecular and Cellular Biology (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)Journal of Bone and Mineral Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Metabolism (1 paper)
- Partner nations
- United StatesUnited KingdomSingapore
In The Last Decade
James Koh
36 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 88
- Oncology 761
- Nephrology 142
- Cancer Research 223
- Aging 24
- Molecular Biology 914
Countries citing papers authored by James Koh
This map shows the geographic impact of James Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Koh more than expected).
Fields of papers citing papers by James Koh
This network shows the impact of papers produced by James Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Koh. The network helps show where James Koh may publish in the future.
Co-authors
The 25 scholars most cited alongside James Koh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 462 | |
| 2 | 1996 | 172 | |
| 3 | 1997 | 169 | |
| 4 | 2000 | 121 | |
| 5 | 1993 | 88 | |
| 6 | 2013 | 62 | |
| 7 | 2003 | 61 | |
| 8 | 2014 | 52 | |
| 9 | 2016 | 43 | |
| 10 | 2010 | 40 | |
| 11 | 2011 | 39 | |
| 12 | 2014 | 39 | |
| 13 | 2015 | 28 | |
| 14 | 2001 | 21 | |
| 15 | 2000 | 21 | |
| 16 | 1987 | 15 | |
| 17 | 2007 | 12 | |
| 18 | 2015 | 10 | |
| 19 | 2019 | 9 | |
| 20 | 2018 | 9 |
About James Koh
James Koh is a scholar working on Molecular Biology, Oncology, Nephrology, Genetics and Physiology, having authored 38 papers that have together received 1.5k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (13 papers), Cancer-related Molecular Pathways (9 papers), Epigenetics and DNA Methylation (6 papers), Genetic Syndromes and Imprinting (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Ubiquitin and proteasome pathways (3 papers), Telomeres, Telomerase, and Senescence (3 papers) and Ophthalmology and Visual Impairment Studies (2 papers). The work is most often cited by research in Oncology (761 citations), Nephrology (142 citations), Cancer Research (223 citations), Aging (24 citations) and Molecular Biology (914 citations). James Koh has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Greg H. Enders, Ed Harlow, Brian David Dynlacht, James C. Garbe, Martha R. Stampfer, Thomas J. Sferra, FS Collins, John A. Olson, Robert Hurford and Marie Classon. Their work appears in journals such as Molecular and Cellular Biology, The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research, Proceedings of the National Academy of Sciences and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.